The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global bone densitometer market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.1% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A bone densitometer, also known as a DXA machine, refers to a device that utilizes a minimal dose of ionizing radiation to measure bone loss and the amount of calcium and other minerals in a bone segment. There are two types of DXA equipment, namely central and peripheral devices. The central devices are used to measure the bone density of the hip and spine, and are usually flat and broad, with an arm overhead. On the other hand, peripheral devices are smaller in size and are mainly used to check bone density in wrists, heels, or fingers. It is the standardized method of diagnosing osteoporosis, as it requires no special preparations and a relatively shorter duration than other procedures. It is also used for assessing an individual’s risk for developing osteoporotic fractures.
One of the major drivers of the bone densitometer market is the rise in geriatric population who are highly susceptible to bone-related ailments. This, along with the growing incidents of fragility fracture, is significantly contributing to the market growth. Apart from this, these devices are crucial in diagnosing osteoporosis and osteopenia, owing to which they are widely utilized for bone density testing in several hospitals and healthcare clinics. Other factors, such as advancements in DXA scanners, which have enabled quicker and more accurate diagnosis, along with increasing investments to improve the existing healthcare infrastructure, are expected to further create a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone densitometer market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on device type, technology, application and end-user.
Breakup by Device Type:
Breakup by Technology:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB, Swissray Global Healthcare Holding Ltd., etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Device Type, Technology, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Ampall Co. Ltd., BeamMed Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, GE Healthcare, Hologic Inc., Medonica Co. Ltd., Scanflex Healthcare AB and Swissray Global Healthcare Holding Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at